January 2017 Newsletter

//January 2017 Newsletter

January 2017 Survey – How do you think the Trump administration will impact health care for people with diabetes?

By | 2017-01-23T16:32:25+00:00 January 23rd, 2017|Diabetes Bites, January 2017 Newsletter|

View the results of last month's survey and VOTE a new January survey!

Tresiba gains FDA approval for use in children and adolescents

By | 2017-01-23T22:05:53+00:00 January 18th, 2017|Diabetes Bites, January 2017 Newsletter|

Children and adolescents age 1 and up now have another option in basal insulin. On December 19, 2016, Novo Nordisk announced that the FDA approved an expanded indication for Tresiba (insulin degludec injection 100 U/mL, 200 U/mL).

Medicare to Begin Covering CGMs… But Are You “Worthy”?

By | 2017-01-18T19:43:13+00:00 January 18th, 2017|Diabetes Bites, January 2017 Newsletter|

After more than a decade of advocacy efforts, Medicare will finally start to cover CGM. However, coverage will be determined on a case-by-case basis. Are you CGM-Worthy???

New Lilly program provides discounted insulin pricing

By | 2017-01-18T19:35:00+00:00 January 18th, 2017|Diabetes Bites, January 2017 Newsletter|

If you are paying full retail pricing at the pharmacy for insulin because you do not have insurance, or are in the deductible phase of your high-deductible insurance plan, you may soon be able to get a little relief.

New Hope: Glucagon for the dual hormone artificial pancreas

By | 2017-01-18T19:24:02+00:00 January 18th, 2017|Diabetes Bites, January 2017 Newsletter|

We are all so eager for a commercially available closed-loop "bionic pancreas" system to hit the market. But glucagon isn't stable for any great length of time after it is reconstituted, so researchers are working on developing a more stable version of it. Read on to learn more about progress on that front!